> top > docs > PMC:7319919 > spans > 6725-6912 > annotations

PMC:7319919 / 6725-6912 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T40 169-177 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T68 52-53 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T52 119-138 Chemical denotes lopinavir/ritonavir http://purl.obolibrary.org/obo/CHEBI_145924
T53 119-128 Chemical denotes lopinavir http://purl.obolibrary.org/obo/CHEBI_31781
T54 129-138 Chemical denotes ritonavir http://purl.obolibrary.org/obo/CHEBI_45409
T55 140-148 Chemical denotes imatinib http://purl.obolibrary.org/obo/CHEBI_45783

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
167 178-186 Species denotes patients Tax:9606
168 119-138 Chemical denotes lopinavir/ritonavir MESH:C558899
169 140-148 Chemical denotes imatinib MESH:D000068877
170 154-165 Chemical denotes baricitinib MESH:C000596027
171 169-177 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T52 0-187 Sentence denotes David Bernal-Bello is the principal investigator of a non-sponsored randomized trial assessing the therapeutic role of lopinavir/ritonavir, imatinib, and baricitinib in COVID-19 patients.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T94 119-128 DG_23 denotes lopinavir
T95 129-138 DG_30 denotes ritonavir
T96 140-148 CHEBI:14434;CHEBI:14434 denotes imatinib
T97 154-165 DG_41 denotes baricitinib
T98 169-177 SP_7 denotes COVID-19
T99569 119-128 DG_23 denotes lopinavir
T38180 129-138 DG_30 denotes ritonavir
T67623 140-148 CHEBI:14434;CHEBI:14434 denotes imatinib
T63693 154-165 DG_41 denotes baricitinib
T80737 169-177 SP_7 denotes COVID-19